SOSV
SOSV is a global venture capital firm that supports early-stage startups through active, founder-first development programs. Its flagship initiatives HAX and IndieBio provide facilities, engineering resources, services, and laboratory equipment to accelerate product development and prepare companies for subsequent funding rounds. SOSV focuses on deep technology across health, environmental, and cross-border software sectors, aiming to solve human and planetary health challenges. In addition to providing capital, the firm emphasizes intensive programmatic support to help portfolio companies move quickly from seed toward growth, including customer acquisition and scale. The firm operates globally with a bias toward startups targeting rapid international expansion, especially in Asia, and tends to back a small cohort of high-potential companies to accelerate their progress and attract leading investors.
Top Sectors
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Health Care
InnSight Technology
Seed Round in 2025
InnSight Technology is a biotechnology company focused on advancing the diagnostics and evaluation of eye diseases. The company specializes in developing innovative ophthalmic devices, including a novel, hand-held biosensor designed for the detection of anterior ophthalmic injuries. Additionally, InnSight Technology works on the development of nanotechnology-based medical devices aimed at addressing various clinical needs in ophthalmology. By providing these advanced tools, the company enables clinicians to enhance ocular care and improve patient outcomes in eye health.
Ten63 Therapeutics
Series A in 2024
Ten63 Therapeutics, Inc. is a biotechnology company based in Chapel Hill, North Carolina, focused on developing potent therapeutics for medically validated yet undruggable targets. Founded in 2017, the company utilizes its innovative platform, COPPER, which combines machine learning-based computational chemistry with advanced physical modeling to explore an extensive chemical space. This approach allows Ten63 Therapeutics to discover novel drug candidates for some of the most lethal diseases by employing proprietary algorithms for scaffold redesign and optimizing chemical design. By integrating these technologies, the company aims to produce durable therapies and improve drug resistance prediction, ultimately addressing challenges in drug development for previously intractable targets.
Unlocked Labs
Seed Round in 2024
Unlocked Labs develops targeted probiotics designed to manage specific health conditions. Their first product focuses on reducing kidney stone risk by digesting a stone-forming compound found in healthy foods like leafy vegetables.
BioLattice
Seed Round in 2024
BioLattice is a biotechnology company focused on developing tissue-engineered cornea technology. Their primary goal is to provide a viable alternative to donor tissue for full-thickness corneal transplants. The company's innovative technology offers a corneal prototype with vision-correcting capabilities, aiming to restore sight for patients requiring corneal transplants.
FREZENT
Seed Round in 2024
FREZENT is a biotechnology company focused on developing innovative therapeutics for advanced-stage cancer patients. It specializes in creating biological inhibitors that target cancer-specific lipid metabolism, aiming to prevent the reactivation of dormant cancer cells.
Tinkeso Therapeutics
Seed Round in 2024
Tinkeso Therapeutics is a biotechnology company specializing in the development of innovative, off-the-shelf cell therapies for treating cancer and autoimmune diseases. The company focuses on creating allogeneic chimeric antigen receptor (CAR) engineered natural killer T (NKT) cell therapies, which use NKT cells to target and destroy cancer cells or modulate the immune response in autoimmune conditions. This approach aims to increase treatment accessibility and scalability by utilizing non-patient-specific cells.
ZiO Health
Convertible Note in 2024
ZiO Health is a biotechnology company that develops pocket-sized devices featuring proprietary biosensor technology and machine learning algorithms. These devices enable real-time laboratory testing at the point-of-care, enhancing patient care by combining immediate results with individual patient profiles.
Flashaid
Seed Round in 2024
Flashaid offers a tech-enabled platform that connects patients, hospitals, and multiple stakeholders, enabling coordinated care and streamlined interactions across the healthcare ecosystem.
BioLattice
Seed Round in 2024
BioLattice is a biotechnology company focused on developing tissue-engineered cornea technology. Their primary goal is to provide a viable alternative to donor tissue for full-thickness corneal transplants. The company's innovative technology offers a corneal prototype with vision-correcting capabilities, aiming to restore sight for patients requiring corneal transplants.
XN Health
Convertible Note in 2024
XN Health is a medical device company founded in 2021 and based in Texas, USA. The company focuses on developing innovative healthcare solutions to assist mechanically ventilated patients in weaning off ventilators more efficiently. Its primary product utilizes phrenic nerve stimulation to induce diaphragm contractions, thereby mitigating the risks of diaphragm dysfunction associated with prolonged mechanical ventilation. By enhancing the weaning process, XN Health aims to improve patient outcomes and facilitate recovery in critical care settings.
Chronus Health
Convertible Note in 2024
Chronus Health develops a portable diagnostic device for delivering point-of-care lab results in minutes. Its device enables real-time diagnosis at the point-of-care, improving time to care and patient outcomes.
Unlocked Labs
Seed Round in 2023
Unlocked Labs develops targeted probiotics designed to manage specific health conditions. Their first product focuses on reducing kidney stone risk by digesting a stone-forming compound found in healthy foods like leafy vegetables.
Rizlab Health
Convertible Note in 2023
Founded in 2018, Rizlab Health specializes in developing compact blood diagnostic devices. Their flagship product is CytoTracker, a pocket-sized, wireless analyzer powered by artificial intelligence, designed to deliver rapid and affordable white blood cell count analysis.
FREZENT
Seed Round in 2023
FREZENT is a biotechnology company focused on developing innovative therapeutics for advanced-stage cancer patients. It specializes in creating biological inhibitors that target cancer-specific lipid metabolism, aiming to prevent the reactivation of dormant cancer cells.
Ten63 Therapeutics
Series A in 2023
Ten63 Therapeutics, Inc. is a biotechnology company based in Chapel Hill, North Carolina, focused on developing potent therapeutics for medically validated yet undruggable targets. Founded in 2017, the company utilizes its innovative platform, COPPER, which combines machine learning-based computational chemistry with advanced physical modeling to explore an extensive chemical space. This approach allows Ten63 Therapeutics to discover novel drug candidates for some of the most lethal diseases by employing proprietary algorithms for scaffold redesign and optimizing chemical design. By integrating these technologies, the company aims to produce durable therapies and improve drug resistance prediction, ultimately addressing challenges in drug development for previously intractable targets.
Care Constitution
Seed Round in 2023
Care Constitution operates a telehealth platform that facilitates remote medical consultations. It uses AI to analyze sound and images during virtual appointments, generating real-time clinical data and automated assessments for healthcare providers.
Midoconline
Convertible Note in 2023
Midoconline is a technology company focused on improving quality of life through medical and wellness services. It has developed a telehealth platform that facilitates video-based consultations between patients and healthcare professionals. Through its mobile application, Midoconline enables users to connect with doctors for remote consultations regarding non-emergency medical issues, thereby enhancing access to healthcare services.
Metabolomic Diagnostics
Seed Round in 2022
Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.
Abby's Better
Seed Round in 2022
Abby’s Better produces minimally processed, plant-based nut butter snacks and spreads. Their products are all-natural, gluten-free, peanut-free, vegan-friendly, and paleo-compliant, offering health-conscious consumers convenient, wholesome options.
Flashaid
Seed Round in 2022
Flashaid offers a tech-enabled platform that connects patients, hospitals, and multiple stakeholders, enabling coordinated care and streamlined interactions across the healthcare ecosystem.
Metabolomic Diagnostics
Convertible Note in 2022
Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.
Chronus Health
Series A in 2022
Chronus Health develops a portable diagnostic device for delivering point-of-care lab results in minutes. Its device enables real-time diagnosis at the point-of-care, improving time to care and patient outcomes.
Unlocked Labs
Seed Round in 2021
Unlocked Labs develops targeted probiotics designed to manage specific health conditions. Their first product focuses on reducing kidney stone risk by digesting a stone-forming compound found in healthy foods like leafy vegetables.
XN Health
Seed Round in 2021
XN Health is a medical device company founded in 2021 and based in Texas, USA. The company focuses on developing innovative healthcare solutions to assist mechanically ventilated patients in weaning off ventilators more efficiently. Its primary product utilizes phrenic nerve stimulation to induce diaphragm contractions, thereby mitigating the risks of diaphragm dysfunction associated with prolonged mechanical ventilation. By enhancing the weaning process, XN Health aims to improve patient outcomes and facilitate recovery in critical care settings.
Prothegen
Convertible Note in 2021
Prothegen is a biotechnology company located in Palo Alto, California, focused on developing innovative medicines that precisely regulate cell death. The company has created a platform aimed at delivering therapies that can either inhibit or promote ferroptosis, a form of regulated cell death. By targeting this mechanism, Prothegen seeks to provide effective therapeutics that can prevent unwanted cell death, thereby improving treatment options for various diseases.
Prothegen
Seed Round in 2021
Prothegen is a biotechnology company located in Palo Alto, California, focused on developing innovative medicines that precisely regulate cell death. The company has created a platform aimed at delivering therapies that can either inhibit or promote ferroptosis, a form of regulated cell death. By targeting this mechanism, Prothegen seeks to provide effective therapeutics that can prevent unwanted cell death, thereby improving treatment options for various diseases.
Rizlab Health
Convertible Note in 2021
Founded in 2018, Rizlab Health specializes in developing compact blood diagnostic devices. Their flagship product is CytoTracker, a pocket-sized, wireless analyzer powered by artificial intelligence, designed to deliver rapid and affordable white blood cell count analysis.
Rizlab Health
Seed Round in 2021
Founded in 2018, Rizlab Health specializes in developing compact blood diagnostic devices. Their flagship product is CytoTracker, a pocket-sized, wireless analyzer powered by artificial intelligence, designed to deliver rapid and affordable white blood cell count analysis.
Chirp
Seed Round in 2021
Chirp is a platform that provides a safer home for aging adults. It is an easy-to-use solution that helps monitor your loved one.
Chirp offers peace of mind through non-wearable sensing and is less invasive than camera monitoring.
The CareVoice
Series B in 2021
The CareVoice Limited is a Shanghai-based company founded in 2013 that specializes in mobile-based, data-driven software solutions aimed at enhancing the healthcare experience in China. The company provides a platform that offers community-sourced ratings and recommendations for healthcare services, including hospitals, doctors, and treatments. Patients can share their experiences through ratings and reviews, fostering a collaborative environment for individuals undergoing similar medical journeys. By digitalizing the healthcare and insurance processes, The CareVoice aims to create a more consumer-centric approach to healthcare, facilitating better decision-making for patients and improving overall patient experiences. The company also has an office in Hong Kong, reflecting its international presence in the health insurtech sector.
Oralta
Seed Round in 2021
Oralta is a United States-based company specializing in the production of probiotic supplements aimed at improving oral health. The company manufactures FRESH BREATH, a line of chewable tablets designed to combat bad breath by targeting odor-producing bacteria. These probiotics work by restoring a healthy balance of beneficial bacteria in the mouth, effectively eliminating the harmful germs responsible for unpleasant odors. In addition to addressing bad breath, Oralta's products also focus on broader oral health issues, such as tooth decay and gum disease. By inactivating the byproducts of these harmful bacteria, Oralta supports sustainable oral hygiene practices, allowing users to maintain their overall dental well-being.
Midoconline
Seed Round in 2021
Midoconline is a technology company focused on improving quality of life through medical and wellness services. It has developed a telehealth platform that facilitates video-based consultations between patients and healthcare professionals. Through its mobile application, Midoconline enables users to connect with doctors for remote consultations regarding non-emergency medical issues, thereby enhancing access to healthcare services.
Chronus Health
Convertible Note in 2021
Chronus Health develops a portable diagnostic device for delivering point-of-care lab results in minutes. Its device enables real-time diagnosis at the point-of-care, improving time to care and patient outcomes.
Abby's Better
Convertible Note in 2021
Abby’s Better produces minimally processed, plant-based nut butter snacks and spreads. Their products are all-natural, gluten-free, peanut-free, vegan-friendly, and paleo-compliant, offering health-conscious consumers convenient, wholesome options.
Basin Genomics
Convertible Note in 2021
Basin Genomics is combining scientific backgrounds in genomics and oncology with startup expertise to translate genetic discoveries into advances in personalized clinical care as it strives to develop technology that will decrease the rates of cervical cancer globally.
Basin Genomics
Seed Round in 2021
Basin Genomics is combining scientific backgrounds in genomics and oncology with startup expertise to translate genetic discoveries into advances in personalized clinical care as it strives to develop technology that will decrease the rates of cervical cancer globally.
EMBER Medical
Convertible Note in 2021
EMBER Medical is a telehealth company based in San Francisco, California, founded in 2018. It develops a mobile application that connects individuals experiencing medical emergencies with nearby healthcare professionals, including physicians, nurses, and emergency medical technicians, within a five-minute radius. The application features in-app audio and video capabilities, allowing users to communicate directly with medical staff for immediate assistance. EMBER Medical aims to enhance the accessibility of healthcare, particularly in underserved areas, by providing a platform that enables patients to receive timely and personalized care without the need for in-person visits. The company's technology also offers healthcare providers various tools to manage virtual consultations effectively.
Ten63 Therapeutics
Seed Round in 2021
Ten63 Therapeutics, Inc. is a biotechnology company based in Chapel Hill, North Carolina, focused on developing potent therapeutics for medically validated yet undruggable targets. Founded in 2017, the company utilizes its innovative platform, COPPER, which combines machine learning-based computational chemistry with advanced physical modeling to explore an extensive chemical space. This approach allows Ten63 Therapeutics to discover novel drug candidates for some of the most lethal diseases by employing proprietary algorithms for scaffold redesign and optimizing chemical design. By integrating these technologies, the company aims to produce durable therapies and improve drug resistance prediction, ultimately addressing challenges in drug development for previously intractable targets.
Plasma Nutrition
Convertible Note in 2020
Transforming the performance of protein powders through our patent-pending Ingredient Optimization process to increase sustainability and improve health outcomes.
Babybe
Debt Financing in 2020
Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.
Rambuhealth
Seed Round in 2020
Rambuhealth is a company that specializes in producing a natural antioxidant ingredient derived from the exotic rambutan fruit. This ingredient is utilized in beverages aimed at preventing diseases such as cancer, diabetes, and hypertension. By focusing on environmentally friendly methods, Rambuhealth offers a functional product that not only supports disease prevention but also enhances health, welfare, and overall quality of life at an affordable price. In addition to its preventive properties, the antioxidant ingredient also aids in regulating blood sugar levels, provides energy, and supports muscle recovery after exercise, making it a versatile addition to health-conscious consumers' diets.
Metabolomic Diagnostics
Convertible Note in 2020
Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.
Ivy Natal
Seed Round in 2020
Ivy Natal is a biotechnology company focused on addressing infertility through innovative reproductive solutions. The company has developed a skin biopsy technology that enables the creation of human egg cells from skin samples. This process activates the existing DNA within skin cells to transform them into healthy egg cells, offering a novel alternative to traditional in vitro methods for producing eggs and sperm. By circumventing the challenges associated with conventional reproductive techniques, Ivy Natal aims to provide couples, including those in same-sex relationships, with the opportunity to have genetically related children.
Chronus Health
Seed Round in 2020
Chronus Health develops a portable diagnostic device for delivering point-of-care lab results in minutes. Its device enables real-time diagnosis at the point-of-care, improving time to care and patient outcomes.
Babybe
Convertible Note in 2019
Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.
Farma Genetix
Seed Round in 2019
Farma Genetix is a Boston-based company that specializes in manufacturing genetically tailored natural supplements and personalized diet plans aimed at addressing chronic health conditions. By collaborating with researchers from Harvard Medical School's Genomics department, Farma Genetix develops nutritional products designed to support cardiovascular health, including the maintenance of healthy blood pressure and cholesterol levels. The company emphasizes the importance of a customized dietary approach to promote overall well-being and reinforce a healthy lifestyle.
Ten63 Therapeutics
Seed Round in 2019
Ten63 Therapeutics, Inc. is a biotechnology company based in Chapel Hill, North Carolina, focused on developing potent therapeutics for medically validated yet undruggable targets. Founded in 2017, the company utilizes its innovative platform, COPPER, which combines machine learning-based computational chemistry with advanced physical modeling to explore an extensive chemical space. This approach allows Ten63 Therapeutics to discover novel drug candidates for some of the most lethal diseases by employing proprietary algorithms for scaffold redesign and optimizing chemical design. By integrating these technologies, the company aims to produce durable therapies and improve drug resistance prediction, ultimately addressing challenges in drug development for previously intractable targets.
The CareVoice
Series A in 2019
The CareVoice Limited is a Shanghai-based company founded in 2013 that specializes in mobile-based, data-driven software solutions aimed at enhancing the healthcare experience in China. The company provides a platform that offers community-sourced ratings and recommendations for healthcare services, including hospitals, doctors, and treatments. Patients can share their experiences through ratings and reviews, fostering a collaborative environment for individuals undergoing similar medical journeys. By digitalizing the healthcare and insurance processes, The CareVoice aims to create a more consumer-centric approach to healthcare, facilitating better decision-making for patients and improving overall patient experiences. The company also has an office in Hong Kong, reflecting its international presence in the health insurtech sector.
Rize Health
Seed Round in 2019
Rize Health operates a virtual marketplace and patient management platform for clinical trials, connecting patients with suitable studies and enabling digital participation. The platform supports onboarding, scheduling, and remote data capture to streamline enrollment and reduce dropout rates for researchers, while improving trial efficiency. Headquartered in London, Ontario, the company focuses on patient engagement through a patient-centric interface that matches individuals to appropriate trials.
ZiO Health
Seed Round in 2019
ZiO Health is a biotechnology company that develops pocket-sized devices featuring proprietary biosensor technology and machine learning algorithms. These devices enable real-time laboratory testing at the point-of-care, enhancing patient care by combining immediate results with individual patient profiles.
Chronus Health
Seed Round in 2019
Chronus Health develops a portable diagnostic device for delivering point-of-care lab results in minutes. Its device enables real-time diagnosis at the point-of-care, improving time to care and patient outcomes.
Bioptamers
Seed Round in 2019
Bioptamers develops personalized cancer therapies using synthetic aptamers, which are short nucleic acid molecules that selectively bind to cancer cells. This enables targeted delivery of chemotherapy, radiation, and immunotherapy agents, aiming to improve clinical outcomes for cancer patients.
Babybe
Convertible Note in 2018
Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.
Achiko
Seed Round in 2018
Achiko AG is a technology-driven company based in Zürich, Switzerland, with additional offices in Jakarta and Singapore. Established in 2018, it focuses on developing innovative diagnostic solutions and mobile health applications. Its flagship product is a rapid, affordable, and accurate Covid-19 test, which is accompanied by a user-friendly app that serves as a digital health passport. The company's biotechnology division, AptameX, specializes in creating aptamer-based diagnostics, while its digital health technology division, Teman Sehat, enhances the user experience through companion health apps. Achiko's products are designed to be cost-effective and can be rapidly synthesized, positioning the company to address a wide array of disease diagnostics and therapeutic indications in the evolving healthcare landscape.
NewPath Probiotics
Seed Round in 2018
NewPath Probiotics is a Chicago-based company founded in 2018 that specializes in the manufacture of probiotic medicine specifically designed for the treatment of sinus-related issues. The company's primary product, New Path Probiotics Sinus Rinse, offers relief from sinus problems and addresses sinus microbes through an organic and natural formulation. This innovative approach serves as an alternative to traditional over-the-counter nasal steroids, allowing customers to alleviate congestion using natural ingredients.
Chronus Health
Seed Round in 2018
Chronus Health develops a portable diagnostic device for delivering point-of-care lab results in minutes. Its device enables real-time diagnosis at the point-of-care, improving time to care and patient outcomes.
Babybe
Series A in 2018
Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.
EMBER Medical
Seed Round in 2018
EMBER Medical is a telehealth company based in San Francisco, California, founded in 2018. It develops a mobile application that connects individuals experiencing medical emergencies with nearby healthcare professionals, including physicians, nurses, and emergency medical technicians, within a five-minute radius. The application features in-app audio and video capabilities, allowing users to communicate directly with medical staff for immediate assistance. EMBER Medical aims to enhance the accessibility of healthcare, particularly in underserved areas, by providing a platform that enables patients to receive timely and personalized care without the need for in-person visits. The company's technology also offers healthcare providers various tools to manage virtual consultations effectively.
ZiO Health
Seed Round in 2018
ZiO Health is a biotechnology company that develops pocket-sized devices featuring proprietary biosensor technology and machine learning algorithms. These devices enable real-time laboratory testing at the point-of-care, enhancing patient care by combining immediate results with individual patient profiles.
Metabolomic Diagnostics
Seed Round in 2018
Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.
Hippo and Crate
Seed Round in 2018
Hippo & Crate Limited, established in 2016 and headquartered in Jing'an, China, specializes in the direct-to-consumer (D2C) distribution of high-quality oral care products. The company offers a subscription-based service for toothpaste, toothbrushes, mouthwash, and other complementary items, focusing on design, production, and distribution. Hippo & Crate aims to improve oral hygiene quality while promoting environmental responsibility through its products.
The CareVoice
Seed Round in 2018
The CareVoice Limited is a Shanghai-based company founded in 2013 that specializes in mobile-based, data-driven software solutions aimed at enhancing the healthcare experience in China. The company provides a platform that offers community-sourced ratings and recommendations for healthcare services, including hospitals, doctors, and treatments. Patients can share their experiences through ratings and reviews, fostering a collaborative environment for individuals undergoing similar medical journeys. By digitalizing the healthcare and insurance processes, The CareVoice aims to create a more consumer-centric approach to healthcare, facilitating better decision-making for patients and improving overall patient experiences. The company also has an office in Hong Kong, reflecting its international presence in the health insurtech sector.
Daeki
Seed Round in 2017
Daeki has developed the saliva-based diabetes detection test, which provides a simple, quick and non-invasive alternative for patients to detect diabetes or prediabetes conditions at home.
Mezomax
Seed Round in 2017
MezoMax, Inc. is a biotechnology company based in San Francisco, California, founded in 2017. The company specializes in developing oral therapies aimed at accelerating the healing of nonhealing fractures and enhancing bone health. MezoMax's innovative approach involves a novel calcium gluconate stereoisomer that regulates calcium and mineral metabolism, facilitating faster bone fracture healing and improving treatment for osteoporosis, particularly in elderly patients. By focusing on preclinical orthopedics, MezoMax aims to provide a safer and more effective mechanism for stimulating bone-forming cells and addressing various bone diseases, including rare conditions linked to bone health.
Nivien Therapeutics
Seed Round in 2017
Nivien Therapeutics is a biomedical company focused on developing medicines that enhance chemotherapy and immunotherapy for treatment-resistant cancers. Founded in 2016 and based in Boston, Massachusetts, the company has developed first small-molecule inhibitors targeting the Hippo signaling pathway, a mechanism implicated in cancer resistance. Its program aims to de-risk transfers of technology assets from leading research institutes and to build a platform that advances IO-chemo combination therapies, with an emphasis on expanding options for patients who do not respond to standard treatments.
Babybe
Convertible Note in 2017
Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.
Abby's Better
Seed Round in 2017
Abby’s Better produces minimally processed, plant-based nut butter snacks and spreads. Their products are all-natural, gluten-free, peanut-free, vegan-friendly, and paleo-compliant, offering health-conscious consumers convenient, wholesome options.
ZiO Health
Convertible Note in 2017
ZiO Health is a biotechnology company that develops pocket-sized devices featuring proprietary biosensor technology and machine learning algorithms. These devices enable real-time laboratory testing at the point-of-care, enhancing patient care by combining immediate results with individual patient profiles.
SwaLife Biotech
Seed Round in 2017
Founded in 2017, SwaLife Biotech specializes in discovering and developing medicinal compounds derived from plants. The company focuses on novel anticancer plant alkaloids targeting DNA damage response for both cosmetic and medical applications.
ZiO Health
Seed Round in 2017
ZiO Health is a biotechnology company that develops pocket-sized devices featuring proprietary biosensor technology and machine learning algorithms. These devices enable real-time laboratory testing at the point-of-care, enhancing patient care by combining immediate results with individual patient profiles.
JOY Familytech
Convertible Note in 2017
JOY Familytech Inc. is a family and health technology company based in San Francisco, known for its innovative wearables designed to assist in child development. Founded in 2017, the company produces products such as the Octopus Watch, which serves as a multifunctional tool for children, incorporating the teaching of good habits, time management, and self-discipline. In addition to its wearable devices, JOY Familytech has developed the JOY behavioral platform, which leverages artificial intelligence to provide personalized routines and adaptive coaching for children. These offerings not only aim to foster responsibility and independence among young users but also aim to empower families by establishing structure and support in children's daily lives. The company sells its products through its own platform and various online retail channels.
JOY Familytech
Seed Round in 2017
JOY Familytech Inc. is a family and health technology company based in San Francisco, known for its innovative wearables designed to assist in child development. Founded in 2017, the company produces products such as the Octopus Watch, which serves as a multifunctional tool for children, incorporating the teaching of good habits, time management, and self-discipline. In addition to its wearable devices, JOY Familytech has developed the JOY behavioral platform, which leverages artificial intelligence to provide personalized routines and adaptive coaching for children. These offerings not only aim to foster responsibility and independence among young users but also aim to empower families by establishing structure and support in children's daily lives. The company sells its products through its own platform and various online retail channels.
The CareVoice
Seed Round in 2017
The CareVoice Limited is a Shanghai-based company founded in 2013 that specializes in mobile-based, data-driven software solutions aimed at enhancing the healthcare experience in China. The company provides a platform that offers community-sourced ratings and recommendations for healthcare services, including hospitals, doctors, and treatments. Patients can share their experiences through ratings and reviews, fostering a collaborative environment for individuals undergoing similar medical journeys. By digitalizing the healthcare and insurance processes, The CareVoice aims to create a more consumer-centric approach to healthcare, facilitating better decision-making for patients and improving overall patient experiences. The company also has an office in Hong Kong, reflecting its international presence in the health insurtech sector.
Babybe
Series A in 2016
Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.
JOY Familytech
Convertible Note in 2016
JOY Familytech Inc. is a family and health technology company based in San Francisco, known for its innovative wearables designed to assist in child development. Founded in 2017, the company produces products such as the Octopus Watch, which serves as a multifunctional tool for children, incorporating the teaching of good habits, time management, and self-discipline. In addition to its wearable devices, JOY Familytech has developed the JOY behavioral platform, which leverages artificial intelligence to provide personalized routines and adaptive coaching for children. These offerings not only aim to foster responsibility and independence among young users but also aim to empower families by establishing structure and support in children's daily lives. The company sells its products through its own platform and various online retail channels.
Plasma Nutrition
Convertible Note in 2016
Transforming the performance of protein powders through our patent-pending Ingredient Optimization process to increase sustainability and improve health outcomes.
Metabolomic Diagnostics
Venture Round in 2016
Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.
Cell Reserves
Seed Round in 2016
Cell Reserves is a Canadian biopharmaceutical company specializing in the development of protein and peptide-based therapeutics. It employs molecular shields to enhance the bio-availability and longevity of these therapies, aiming to improve treatment outcomes for autoimmune diseases and excessive inflammation.
Barley + Oats
Convertible Note in 2016
Barley + Oats Inc. is a meal delivery service based in Buffalo, New York, established in 2015, that specializes in providing nutrition-focused meals and snacks aimed at supporting female health. The company offers a diverse range of products, including granolas, cookies, teas, herbal coffees, and broths, specifically designed to assist women during key stages such as fertility, pregnancy, breastfeeding, and hormone balance. By prioritizing plant-based ingredients and flavors, Barley + Oats aims to create convenient food choices that promote the long-term health of both mothers and their babies.
Plasma Nutrition
Seed Round in 2016
Transforming the performance of protein powders through our patent-pending Ingredient Optimization process to increase sustainability and improve health outcomes.
KaJin Health
Seed Round in 2016
Kajin, Inc. operates an online therapy and counseling platform specifically designed for Chinese-speaking Asians. Established in 2015 and headquartered in Taipei, Taiwan, the company offers a real-time platform that utilizes live video sessions to connect users with certified therapists. Kajin aims to address mental health issues within minority communities, focusing on reducing stigma and increasing access to mental health resources for the Chinese community. The platform allows patients and counselors to connect anytime and anywhere, facilitating support and guidance for those in need.
Barley + Oats
Pre Seed Round in 2016
Barley + Oats Inc. is a meal delivery service based in Buffalo, New York, established in 2015, that specializes in providing nutrition-focused meals and snacks aimed at supporting female health. The company offers a diverse range of products, including granolas, cookies, teas, herbal coffees, and broths, specifically designed to assist women during key stages such as fertility, pregnancy, breastfeeding, and hormone balance. By prioritizing plant-based ingredients and flavors, Barley + Oats aims to create convenient food choices that promote the long-term health of both mothers and their babies.
JOY Familytech
Pre Seed Round in 2016
JOY Familytech Inc. is a family and health technology company based in San Francisco, known for its innovative wearables designed to assist in child development. Founded in 2017, the company produces products such as the Octopus Watch, which serves as a multifunctional tool for children, incorporating the teaching of good habits, time management, and self-discipline. In addition to its wearable devices, JOY Familytech has developed the JOY behavioral platform, which leverages artificial intelligence to provide personalized routines and adaptive coaching for children. These offerings not only aim to foster responsibility and independence among young users but also aim to empower families by establishing structure and support in children's daily lives. The company sells its products through its own platform and various online retail channels.
Miramix
Seed Round in 2015
Miramix is a Massachusetts-based company that specializes in producing customized nutritional supplements tailored to individual health goals. It operates a marketplace that enables consumers to create their own supplement blends using micro-dosing technology, allowing for precise formulation milligram by milligram. The product offerings include custom supplements, branded supplements, private label supplements, workout supplements, and beauty supplements, catering to a diverse array of dietary needs. By providing both the hardware and software tools necessary for individuals to develop bespoke capsules, Miramix aims to empower consumers to find the optimal nutrient combinations that support their personal health objectives.
The CareVoice
Seed Round in 2015
The CareVoice Limited is a Shanghai-based company founded in 2013 that specializes in mobile-based, data-driven software solutions aimed at enhancing the healthcare experience in China. The company provides a platform that offers community-sourced ratings and recommendations for healthcare services, including hospitals, doctors, and treatments. Patients can share their experiences through ratings and reviews, fostering a collaborative environment for individuals undergoing similar medical journeys. By digitalizing the healthcare and insurance processes, The CareVoice aims to create a more consumer-centric approach to healthcare, facilitating better decision-making for patients and improving overall patient experiences. The company also has an office in Hong Kong, reflecting its international presence in the health insurtech sector.
Babybe
Venture Round in 2015
Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.
Metabolomic Diagnostics
Venture Round in 2014
Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.
Babybe
Pre Seed Round in 2014
Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.
DriftCoast
Seed Round in 2014
DriftCoast is a manufacturer of innovative medical devices, specializing in remote-controlled catheters designed to enhance surgical procedures. The company's flagship product, MACSAir, utilizes leap motion technology and a touchless control interface, allowing surgeons to operate the catheter without physical contact. This technology enables real-time control and visualization of the catheter's movements, utilizing magnetic resonance imaging, which improves the efficiency and safety of surgical interventions. By providing a more interactive experience within the operating room, DriftCoast aims to significantly improve patient outcomes and save lives.
Metabolomic Diagnostics
Venture Round in 2014
Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.
Metabolomic Diagnostics
Seed Round in 2013
Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.
Babybe
Seed Round in 2013
Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.
Metabolomic Diagnostics
Venture Round in 2013
Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.